Externalising disorders
Chapter D.3
Mood disorders
Chapter E.2
Mood disorders
Chapter E.4
2018 edition
Anxiety disorders
Chapter F.2
Anxiety disorders
Chapter F.5
Other disorders Chapter H.1
Other disorders
Chapter H.3
Целью этой главы является представление ключевых элементов, касающихся терапевтического использования психотропных лекарственных средств у детей и подростков, ... также знакомство
клиницистов с общими принципами фармакотерапии психиатрических расстройств в период развития. Для более детального ознакомления со специфическими медикаментами мы рекомендуем читателям обратиться к соответствующим главам, посвященным конкретным расстройствам.
more
A summary of the national drug situation
The official death toll was 447 people as of 25 March, according to the Government.
• Nearly 129,000 people are sheltering in 143 collective sites across Sofala (more than 97,600 people), Manica (more than 14,800 people); Zambezia (more than 9,600 people); and Tete (more than 6,800 people).
...• The entire District of Nhamatanda in Sofala Province has been affected by Cyclone Idai and related floods, and nearly 15,000 people are sheltering in 14 sites across the district
more
Psychiatry and Pediatrics
Chapter I.5
Psychatry & Pediatrics
Chapter I.3
A summary of the national drug situation
Miscellaneous
Chapter J.6
Published: February 23, 2010
https://doi.org/10.1371/journal.pmed.1000235
Volume 7 | Issue 2 | e1000235
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions
expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to
describe the best treatments and pra...ctices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws of their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all dosages and unwanted effects are mentioned. Organizations, publications and websites are cited or linked to illustrate issues or as a source of further information. This does not mean that authors, the Editor or IACAPAP endorse their content or recommendations, which should be critically assessed by the reader. Websites may also change or cease to exist.
more